ClinicalTrials.Veeva

Menu

Continous Assessment of Cerebral Autoregulation With Near-infrared Spectroscopy

Y

Yu Liyun

Status

Unknown

Conditions

Cerebral Blood Flow
Cerebral Perfusion Pressure

Treatments

Device: measure TOI and BP

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Cerebral autoregulation can be explained by a tight coupling between oxygen supply and demand of the brain, and is essential to maintain a constant cerebral blood flow (CBF) in the context of changes in cerebral perfusion pressure. In this study, investigators use Near-infrared spectroscopy (NIRS) to monitor cerebral autoregulation.

Full description

Near-infrared spectroscopy (NIRS) is a noninvasive technology that real-time monitors cerebral tissue oxygenation index (TOI). Investigators use Near-infrared spectroscopy (NIRS) to monitor cerebral autoregulation of hypertensive participants and non-hypertensive participants.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • health people, or people with hypertension

Exclusion criteria

  • diabetes, anemia, liver disease, kidney disease.

Trial design

40 participants in 2 patient groups

normal
Description:
Human without hypertension, diabetes, anemia, liver disease and kidney disease. The group will measure TOI and BP.
Treatment:
Device: measure TOI and BP
hypertension
Description:
Human only have hypertension, without diabetes, anemia, liver disease and kidney disease. Hypertension group will measure TOI and BP.
Treatment:
Device: measure TOI and BP

Trial contacts and locations

0

Loading...

Central trial contact

Liyun Yu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems